NCT01849263 · Interventional trial
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
Overall registry status Active not recruiting
Phase 2
Conditions Grade 3a Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Refractory Follicular Lymphoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory